Precision medicine in diffuse large B-cell lymphoma: Hitting the target Journal Article


Authors: Vermaat, J. S.; Pals, S. T.; Younes, A.; Dreyling, M.; Federico, M.; Aurer, I.; Radford, J.; Kersten, M. J.
Article Title: Precision medicine in diffuse large B-cell lymphoma: Hitting the target
Keywords: signal transduction; cancer chemotherapy; treatment response; gene mutation; lestaurtinib; prednisone; cancer recurrence; sorafenib; doxorubicin; drug efficacy; rituximab; outcome assessment; dna damage; unindexed drug; cancer immunotherapy; bortezomib; gene expression profiling; editorial; cyclophosphamide; vincristine; immunoglobulin enhancer binding protein; high throughput screening; dasatinib; carcinogenesis; cancer genetics; protein bcl 10; tipifarnib; protein bcl 6; large cell lymphoma; medicine; myeloid differentiation factor 88; toll like receptor; enzastaurin; carfilzomib; molecularly targeted therapy; phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); growth factor receptor; b lymphocyte receptor; vemurafenib; pacritinib; ruxolitinib; idelalisib; pictilisib; ibrutinib; buparlisib; human; precision medicine; sotrastaurin; fostamatinib; rigosertib
Journal Title: Haematologica
Volume: 100
Issue: 8
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-08-03
Start Page: 989
End Page: 993
Language: English
DOI: 10.3324/haematol.2015.128371
PROVIDER: scopus
PUBMED: 26314080
PMCID: PMC5004412
DOI/URL:
Notes: Export Date: 2 September 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anas Younes
    319 Younes